sleep apnea tirzepatide VisualAbstract: Improved Outcomes in Patients with Obstructive and Obesity Studies Show Weight Loss Drug

This information helps optimize your treatment approach

The SURMOUNT-4 trial followed adults with obesity who had reached a stable dose of tirzepatide and then either continued the medication or switched to a placebo

Your provider needs to know: Your last tirzepatide dose (date and amount) How long you have been taking it Your current dose level When you estimate conception occurred Whether you were taking oral contraceptives Any other medications you are taking Your provider will likely schedule an early ultrasound, possibly as soon as 6-8 weeks gestation

These effects typically resolve within 48 to 72 hours as the excess drug is metabolized